Journal
/
Immunology and Infection
/
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection

English

Automatically Generated

1,532 Views

•

07:32 min

•

September 01, 2023

DOI:

10.3791/65152-v

DOI:
10.3791/65152-v

•

07:32 min
September 01, 2023

•

1 Views
, , , , , , , , ,
1National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy,Third Military Medical University

Summary

Automatically generated

The present protocol prepares and evaluates the physical properties, immune response, and in vivo protective effect of a novel nanoemulsion adjuvant vaccine.

Explore More Videos

MRSANanoemulsion AdjuvantVaccineImmune ResponseELISAAntigen CoatingSerum DilutionDouble Ratio Dilution

Read Article

Cite this Article

Zeng, X., Sun, H., Ye, Y., Luo, X., Cai, D., Yang, Y., Chen, T., Sun, C., Zhang, S., Zeng, H. Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection. J. Vis. Exp. (199), e65152, doi:10.3791/65152 (2023).

Download .ris file

Copy

Share Video

.

Copy